<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0035-0052</journal-id>
<journal-title><![CDATA[Revista mexicana de pediatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. pediatr.]]></abbrev-journal-title>
<issn>0035-0052</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Pediatría A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0035-00522024000500175</article-id>
<article-id pub-id-type="doi">10.35366/120167</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Comparación de biomarcadores urinarios en niños con obstrucción o dilatación del tracto urinario superior]]></article-title>
<article-title xml:lang="en"><![CDATA[Comparison of urinary biomarkers in children with obstruction or dilation of the upper urinary tract]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Godínez-Álvarez]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramírez-Velázquez]]></surname>
<given-names><![CDATA[Elías]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz-Pardo]]></surname>
<given-names><![CDATA[Mario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Ledón]]></surname>
<given-names><![CDATA[Fernando José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Medeiros-Domingo]]></surname>
<given-names><![CDATA[Mara]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zurita-Cruz]]></surname>
<given-names><![CDATA[Jessie Nallely]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez Departamento de Urología Pediátrica ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Infantil de México Federico Gómez División de Investigación ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2024</year>
</pub-date>
<volume>91</volume>
<numero>5</numero>
<fpage>175</fpage>
<lpage>180</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0035-00522024000500175&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0035-00522024000500175&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0035-00522024000500175&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción:  la dilatación no obstructiva del tracto urinario generalmente es transitoria; sin embargo, existe riesgo de presentar estenosis ureteropiélica (EUP).  Objetivo:  comparar los niveles urinarios de lipocalina asociada con gelatinasa de neutrófilos (NGAL), molécula-1 de lesión renal (KIM-1) y cistatina C entre pacientes con obstrucción del tracto urinario (OTU) o con dilatación no obstructiva del tracto urinario superior (DTU).  Material y métodos:  estudio transversal y comparativo, con pacientes &lt; 18 años con OTU y DTU secundario a EUP. Análisis estadístico: para comparar los niveles de biomarcadores urinarios entre los grupos de estudio se utilizó la prueba de U de Mann-Whitney.  Resultados:  se estudiaron 22 pacientes (18 con OTU y 4 con DTU), con predominio del sexo masculino (n = 16). La mediana para la edad fue de 4.7 meses. Los valores de NGAL en el grupo OTU tuvieron una mediana de 103.75 ng/mgCr, los cuales fueron significativamente mayores que los del grupo DTU (16.71 ng/mgCr), p = 0.049. La mediana de los valores de KIM-1 fueron de 2.11 ng/mgCr, y de 2.29 ng/mgCr, respectivamente (p = 0.829). Por último, para cistatina C las medianas fueron de 12.34 ng/mgCr y de 6.40 ng/mgCr, pero sin diferencia estadística (p = 0.307).  Conclusiones:  en pacientes con EUP, NGAL parece ser un biomarcador útil para diferenciar pacientes con obstrucción de aquéllos con dilatación no obstructiva.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract:  Introduction:  non-obstructive urinary tract dilation is usually transient; however, there is a risk of developing ureteropelvic stricture (UPS).  Objective:  to compare urinary levels of neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), and cystatin C between patients with urinary tract obstruction (UTO) or non-obstructive upper urinary tract dilation (UTD).  Material and methods:  a cross-sectional study was conducted with patients aged &lt; 18 years with OTU and DTU secondary to UPS. Statistical analysis: the Mann-Whitney U test was used to compare urinary biomarker levels between the two study groups.  Results:  twenty-two patients were studied (18 with OTU and 4 with DTU); the majority were male (n = 16). The median age was 4.7 months. NGAL values &#8203;&#8203;in the OTU group had a median of 103.75 ng/mgCr, which was significantly higher than those in the DTU group (16.71 ng/mgCr), p = 0.049. The median KIM-1 values &#8203;&#8203;were 2.11 ng/mgCr and 2.29 ng/mgCr, respectively (p = 0.829). Finally, for cystatin C the medians were 12.34 ng/mgCr and 6.40 ng/mgCr, but with no statistical difference (p = 0.307).  Conclusions:  in patients with UPS, NGAL appears to be a useful biomarker to differentiate patients with obstruction from those with non-obstructive dilation.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[dilatación urinaria]]></kwd>
<kwd lng="es"><![CDATA[hidronefrosis]]></kwd>
<kwd lng="es"><![CDATA[lipocalina asociada con gelatinasa de neutrófilos (NGAL)]]></kwd>
<kwd lng="es"><![CDATA[molécula-1 de lesión renal (KIM-1)]]></kwd>
<kwd lng="es"><![CDATA[cistatina C]]></kwd>
<kwd lng="en"><![CDATA[urinary dilation]]></kwd>
<kwd lng="en"><![CDATA[hydronephrosis]]></kwd>
<kwd lng="en"><![CDATA[neutrophil gelatinase-associated lipocalin (NGAL)]]></kwd>
<kwd lng="en"><![CDATA[kidney injury molecule-1 (KIM-1)]]></kwd>
<kwd lng="en"><![CDATA[cystatin C]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nguyen]]></surname>
<given-names><![CDATA[HT]]></given-names>
</name>
<name>
<surname><![CDATA[Herndon]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gatti]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kirsch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kokorowski]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis]]></article-title>
<source><![CDATA[J Pediatr Urol]]></source>
<year>2010</year>
<volume>6</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>212-31</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balster]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Schiborr]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Brinkmann]]></surname>
<given-names><![CDATA[OA]]></given-names>
</name>
<name>
<surname><![CDATA[Hertle]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obstruktive Uropathien im Kindesalter [Obstructive uropathy in childhood]]]></article-title>
<source><![CDATA[Aktuelle Urol]]></source>
<year>2005</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>317-28</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grapin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Auber]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[de Vries]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Audry]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Helardot]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postnatal management of urinary tract anomalies after antenatal diagnosis]]></article-title>
<source><![CDATA[J Gynecol Obstet Biol Reprod (Paris)]]></source>
<year>2003</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>300-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Panda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renal cortical transit time in the evaluation of prenatally detected presumed pelvi ureteric junction like obstruction: a systematic review]]></article-title>
<source><![CDATA[Indian J Urol]]></source>
<year>2021</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>116-24</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Farrugia]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Hitchcock]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Radford]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Burki]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Robb]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[British Association of Paediatric Urologists consensus statement on the management of the primary obstructive megaureter]]></article-title>
<collab>British Association of Paediatric Urologists</collab>
<source><![CDATA[J Pediatr Urol]]></source>
<year>2014</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-33</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norregaard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mutsaers]]></surname>
<given-names><![CDATA[HAM]]></given-names>
</name>
<name>
<surname><![CDATA[Frokiaer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kwon]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Obstructive nephropathy and molecular pathophysiology of renal interstitial fibrosis]]></article-title>
<source><![CDATA[Physiol Rev]]></source>
<year>2023</year>
<volume>103</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>2827-72</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wasilewska]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taranta-Janusz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Debek]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Zoch-Zwierz]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Kuroczycka-Saniutycz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[KIM-1 and NGAL: new markers of obstructive nephropathy]]></article-title>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2011</year>
<volume>26</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>579-86</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cost]]></surname>
<given-names><![CDATA[NG]]></given-names>
</name>
<name>
<surname><![CDATA[Noh]]></surname>
<given-names><![CDATA[PH]]></given-names>
</name>
<name>
<surname><![CDATA[Devarajan]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Ivancic]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Reddy]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Minevich]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty]]></article-title>
<source><![CDATA[J Urol]]></source>
<year>2013</year>
<volume>190</volume>
<numero>^s4</numero>
<issue>^s4</issue>
<supplement>4</supplement>
<page-range>1462-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lucarelli]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mancini]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Galleggiante]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Rutigliano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vavallo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Battaglia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Emerging urinary markers of renal injury in obstructive nephropathy]]></article-title>
<source><![CDATA[Biomed Res Int]]></source>
<year>2014</year>
<volume>2014</volume>
<page-range>303298</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Noyan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Parmaksiz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dursun]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ezer]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Anarat]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cengiz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis]]></article-title>
<source><![CDATA[J Pediatr Urol]]></source>
<year>2015</year>
<volume>11</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>249.e1-6</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karakus]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Oktar]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kucukgergin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kalelioglu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Seckin]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Atar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary IP-10, MCP-1, NGAL, cystatin-C, and KIM-1 levels in prenatally diagnosed unilateral hydronephrosis: the search for an ideal biomarker]]></article-title>
<source><![CDATA[Urology]]></source>
<year>2016</year>
<volume>87</volume>
<page-range>185-92</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bienias]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Sikora]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential novel biomarkers of obstructive nephropathy in children with hydronephrosis]]></article-title>
<source><![CDATA[Dis Markers]]></source>
<year>2018</year>
<volume>2018</volume>
<page-range>1015726</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[DaJusta]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[McLeod]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Alpert]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Jayanthi]]></surname>
<given-names><![CDATA[VR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urinary antimicrobial peptides: Potential novel biomarkers of obstructive uropathy]]></article-title>
<source><![CDATA[J Pediatr Urol]]></source>
<year>2018</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>238.e1-6</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kostic]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Dos Santos Beozzo]]></surname>
<given-names><![CDATA[GPN]]></given-names>
</name>
<name>
<surname><![CDATA[do Couto]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[AHT]]></given-names>
</name>
<name>
<surname><![CDATA[Lima]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Palmeira]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[First-year profile of biomarkers for early detection of renal injury in infants with congenital urinary tract obstruction]]></article-title>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2019</year>
<volume>34</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1117-28</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pavlaki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Printza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Farmaki]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Stabouli]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Taparkou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sterpi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants]]></article-title>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2020</year>
<volume>35</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>163-70</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ozkuvanc&#305;]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Donmez]]></surname>
<given-names><![CDATA[MI]]></given-names>
</name>
<name>
<surname><![CDATA[Ziylan]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Oktar]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kucukgergin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cetin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis?]]></article-title>
<source><![CDATA[J Pediatr Urol]]></source>
<year>2020</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>844.e1-7</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chevalier]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Congenital urinary tract obstruction: proceedings of the State-Of-The-Art Strategic Planning Workshop-National Institutes of Health, Bethesda, Maryland, USA, 11-12 March 2002]]></article-title>
<source><![CDATA[Pediatr Nephrol]]></source>
<year>2003</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>576-606</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
